Improving normothermic machine perfusion and blood transfusion through biocompatible blood silicification
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2322418121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Chuanyi Lei und 14 weiteren Autor:innen. Beteiligte Einrichtung: MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University …. Hauptthemen laut MEDLINE: Erythrocytes, Silicon Dioxide, Biocompatible Materials. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, | Guangdong Provincial Pearl River Talents Program (), the Program for Guangdong Introducing Innovative and Entrepreneurial Teams.
Abstract (Originalsprache)
The growing world population and increasing life expectancy are driving the need to improve the quality of blood transfusion, organ transplantation, and preservation. Here, to improve the ability of red blood cells (RBCs) for normothermic machine perfusion, a biocompatible blood silicification approach termed “shielding-augmenting RBC-in-nanoscale amorphous silica (SARNAS)” has been developed. The key to RBC surface engineering and structure augmentation is the precise control of the hydrolysis form of silicic acid to realize stabilization of RBC within conformal nanoscale silica-based exoskeletons. The formed silicified RBCs (Si-RBCs) maintain membrane/structural integrity, normal cellular functions (e.g., metabolism, oxygen-carrying capability), and enhance resistance to external stressors as well as tunable mechanical properties, resulting in nearly 100% RBC cryoprotection. In vivo experiments confirm their excellent biocompatibility. By shielding RBC surface antigens, the Si-RBCs provide universal blood compatibility, the ability for allogeneic mechanical perfusion, and more importantly, the possibility for cross-species transfusion. Being simple, reliable, and easily scalable, the SARNAS strategy holds great promise to revolutionize the use of engineered blood for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, People's Republic of China.
- State Key Laboratory of Fluid Power and Mechatronic Systems, Department of Engineering Mechanics, and Center for X-Mechanics, Zhejiang University, Hangzhou 310027, People's Republic of China.
- The Second Affiliated Hospital of Anhui Medical University, Hefei 23060, People's Republic of China.
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM 87131.
- Department of Hepatobiliary Surgery and Liver Transplant Center, The General Hospital of Southern Theater, Guangzhou 510010, People's Republic of China.
- Research Department of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
ORCID-Profile: Chuanyi Lei, Shuhao Ma, Xuejin Li
Förderung
- National Natural Science Foundation of China
- | Guangdong Provincial Pearl River Talents Program ()
- the Program for Guangdong Introducing Innovative and Entrepreneurial Teams
- Natural Science Foundation of Guangdong Province, China
- Science and Technology Project of Guangzhou, China
- Natural Science Foundation of Guangdong-Foshan Joint Funds
- Guangdong Basic and Applied Basic Research Foundation
- 广东省人力资源和社会保障厅 | Guangdong Provincial Pearl River Talents Program
Zitieren
APA
Lei, C., Li, Z., Ma, S., Zhang, Q., Guo, J., Ouyang, Q., Lei, Q., Zhou, L., Yang, J., Lin, J., Ettlinger, R., Wuttke, S., Li, X., Brinker, C. J., & Zhu, W. (2024). Improving normothermic machine perfusion and blood transfusion through biocompatible blood silicification. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2322418121
Vancouver
Lei C, Li Z, Ma S, Zhang Q, Guo J, Ouyang Q, et al. Improving normothermic machine perfusion and blood transfusion through biocompatible blood silicification. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2322418121
BibTeX
@article{Lei2024,
author = {Lei, Chuanyi and Li, Zeyu and Ma, Shuhao and Zhang, Qi and Guo, Jimin and Ouyang, Qing and Lei, Qi and Zhou, Liang and Yang, Junxian and Lin, Jiangguo and Ettlinger, Romy and Wuttke, Stefan and Li, Xuejin and Brinker, C Jeffrey and Zhu, Wei},
title = {Improving normothermic machine perfusion and blood transfusion through biocompatible blood silicification},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2322418121}
}
EUVIMED